Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 16, Issue 6, Pages 517-526
Publisher
Informa UK Limited
Online
2020-04-10
DOI
10.1080/17425255.2020.1754793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
- (2020) Jerome Sarris et al. BMC Psychiatry
- The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
- (2020) Salahaden R. Sultan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
- (2020) Simona Lattanzi et al. CNS DRUGS
- Abrupt withdrawal of cannabidiol (CBD): A randomized trial
- (2020) Lesley Taylor et al. EPILEPSY & BEHAVIOR
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?
- (2019) José Alexandre S. Crippa et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
- (2019) Eva Hoch et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Drug-drug interactions between antiepileptics and cannabinoids
- (2019) Barbara Miziak et al. Expert Opinion on Drug Metabolism & Toxicology
- Efficacy, tolerability and safety of cannabis-based medicines for cancer pain
- (2019) Winfried Häuser et al. SCHMERZ
- The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
- (2019) Albert Batalla et al. Journal of Clinical Medicine
- The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis
- (2019) Karma Rabgay et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
- (2019) Orsolini et al. Medicina-Lithuania
- Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis
- (2019) Renandro de Carvalho Reis et al. EPILEPSY & BEHAVIOR
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
- (2018) Emily Stockings et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
- (2018) Simona Lattanzi et al. DRUGS
- Cannabis-based products for pediatric epilepsy: A systematic review
- (2018) Jesse Elliott et al. EPILEPSIA
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews
- (2017) W. Häuser et al. EUROPEAN JOURNAL OF PAIN
- Medical Cannabinoids in Children and Adolescents: A Systematic Review
- (2017) Shane Shucheng Wong et al. PEDIATRICS
- Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
- (2017) Alline C. Campos et al. Frontiers in Pharmacology
- A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
- (2017) Keane Lim et al. Clinical Psychopharmacology and Neuroscience
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
- (2016) Samuel T. Wilkinson et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
- (2016) Nora D. Volkow et al. JAMA Psychiatry
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems
- (2015) Kevin P. Hill JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endocannabinoid signaling at the periphery: 50 years after THC
- (2015) Mauro Maccarrone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
- (2014) Mauro Maccarrone et al. NATURE REVIEWS NEUROSCIENCE
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Valproic acid pathway
- (2013) Yogita Ghodke-Puranik et al. Pharmacogenetics and Genomics
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started